VR Logo

NGL Fine-Chem Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

39 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 1981

Chairman: --

Managing Director: Rahul J Nachane

Group: --

Listing: BSE: 524774

Headquarters: Mumbai, Maharashtra

Website: www.nglfinechem.com

Key Facts

Market cap: R 235.35 Cr

Revenue (TTM): R 158.79 Cr

Earnings (TTM): R 17.35 Cr

Cash: R 11.83 Cr

Total Debt: R 27.16 Cr

Promoters' ownership: 73.81%

Liquidity: Moderate

52 Week range: R 220.00 - 565.95

Face value: R5.00

Shares outstanding: 61,78,024

10 Years Aggregate:

  • CFO: 63.84 Cr
  • EBITDA: 149.10 Cr
  • Net Profit: 80.93 Cr

Stock Performance

Time Period NGL Fine-Chem S&P BSE Healthcare S&P BSE Small Cap
YTD-10.2924.01-6.68
1 month-1.053.257.93
3 months21.1112.7524.77
1 Year-24.7428.69-7.17
3 Years-2.424.54-7.13
5 Years15.93-0.732.17
10 Years31.7111.243.13
As on 13-Jul-2020
Year NGL Fine-Chem S&P BSE Small Cap S&P BSE Healthcare
2019-3.70-6.85-3.55
2018-9.09-23.41-5.89
201752.0559.640.49
2016-0.881.77-12.88
2015251.786.7615.06
2014289.0969.2447.43
201321.29-11.2322.55